For a firm considering an advanced powered arm, the useful part of FDA’s October 18, 2016, order is the specified route to market. It codifies a class II classification applicable since May 9, 2014, rather than newly authorizing the DEKA Arm System. Subsequent 510(k) premarket notifications for the category must comply with the listed special controls. [2016-25001]

Class II does not mean an exemption from review. FDA explicitly retains premarket notification for these prescription devices. Suppliers must support software safety, mechanical durability, battery performance and other functions with testing. Components intended to operate together must account for the degrees of freedom of the complete arm system, making the system’s combined operation relevant rather than just each part in isolation. [2016-25001]

VA’s May 2014 report helps explain why entry involves more than a regulatory label. It described DEKA’s development with $40 million in DARPA funding and four years of evaluation across VA and military sites. That is the reported history of one development effort, not an estimate of what a competitor must spend. Nor does public funding alone establish that later commercial prices will be low. [prosthetic-detail]

The economic inference is limited but useful: explicit testing requirements let potential entrants identify obligations, while those obligations still demand evidence and execution. The sources do not quantify compliance costs, predict new competitors or demonstrate cheaper devices. VA participated in the development evidence chain, so its account is context rather than independent clinical replication. FDA’s reasonable-assurance standard should likewise not be read as a guarantee of commercial success or risk-free use. [2016-25001][prosthetic-detail]

Source documents

  1. Medical Devices; Physical Medicine Devices; Classification of the Upper Extremity Prosthesis Including a Simultaneously Powered Elbow and/or Shoulder With Greater Than Two Simultaneous Powered Degrees of Freedom and Controlled by Non-Implanted Electrical Componentshttps://www.govinfo.gov/content/pkg/FR-2016-10-18/html/2016-25001.htm
  2. DEKA advanced prosthetic arm gains FDA approvalhttps://www.research.va.gov/currents/spring2014/spring2014-34.cfm